Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

CCCCCCCC
23 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in C4 THERAPEUTICS INC

PRICE T ROWE ASSOCIATES INC /MD/ holds 155,881 shares of CCCC (C4 THERAPEUTICS INC), worth $728,000 as of 2026-Q2. The position was increased (+117.9% shares). CCCC represents 0.0% of PRICE T ROWE ASSOCIATES INC /MD/'s portfolio.

Current Value

$728,000

Current Shares

155,881

Total Value Change

-$48.7M

Total Shares Change

-1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
155,881
+117.9%
$728,0000.0%$4.67
40
2026-Q1
Increased
71,546
+477.0%
$189,0000.0%$2.63
25
2025-Q4
Unchanged
12,400
0.0%
$24,0000.0%$1.91
0
2025-Q3
Unchanged
12,400
0.0%
$28,0000.0%$2.22
0
2025-Q2
Decreased
12,400
-67.5%
$18,0000.0%$1.43
0
2025-Q1
Unchanged
38,143
0.0%
$62,0000.0%$1.60
0
2024-Q4
Decreased
38,143
-90.3%
$138,0000.0%$3.60
0
2024-Q3
Increased
392,004
+529.1%
$2.2M0.0%$5.70
42
2024-Q2
Decreased
62,307
-97.0%
$288,0000.0%$4.62
0
2024-Q1
Decreased
2.1M
-17.3%
$17.3M0.0%$8.17
0
2023-Q4
Increased
2.6M
+17.0%
$14.5M0.0%$5.65
33
2023-Q3
Decreased
2.2M
-22.7%
$4.1M0.0%$1.86
0
2023-Q2
Decreased
2.8M
-1.6%
$7.8M0.0%$2.75
0
2023-Q1
Decreased
2.9M
-1.7%
$9M0.0%$3.14
0
2022-Q4
Decreased
2.9M
-1.3%
$17.3M0.0%$5.90
0
2022-Q3
Decreased
3M
-32.4%
$26M0.0%$8.77
0
2022-Q2
Increased
4.4M
+0.1%
$33M0.0%$7.54
29
2022-Q1
Increased
4.4M
+7.2%
$106.2M0.0%$24.26
32
2021-Q4
Increased
4.1M
+3.2%
$131.5M0.0%$32.20
31
2021-Q3
Increased
4M
+11.7%
$176.8M0.0%$44.68
34
2021-Q2
Increased
3.5M
+69.0%
$134.1M0.0%$37.84
45
2021-Q1
Increased
2.1M
+37.1%
$77.6M0.0%$36.99
39
2020-Q4
New
1.5M
-
$49.4M0.0%$33.13
41

Other major holders of CCCC: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used